Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp
13G
ABUS · 03879J100
|
8.0% |
9/4/2026
Event 9/4/2026
|
|||
| Whitefort Capital Master Fund, LP | 8.0% | ||||
| Whitefort Capital GP, LLC | 8.0% | ||||
| Whitefort Capital Management, LP | 8.0% | ||||
| Whitefort Capital Management GP, LLC | 8.0% | ||||
| David Salanic | 8.0% | ||||
| Joseph Kaplan | 8.0% | ||||
|
OmniAb, Inc.
13G/A
Amendment 3
OABI · 68218J103
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Whitefort Capital Management, LP | 7.1% | ||||
| David Salanic | 7.1% | ||||
| Joseph Kaplan | 7.1% | ||||
|
Arbutus Biopharma Corp
13D/A
Amendment 4
ABUS · 03879J100
|
8.0% |
4/28/2026
Event 4/24/2026
|
|||
| Whitefort Capital Master Fund, LP | 8.0% | ||||
| Whitefort Capital GP, LLC | 8.0% | ||||
| Whitefort Capital Management, LP | 8.0% | ||||
| Whitefort Capital Management GP, LLC | 8.0% | ||||
| David Salanic | 8.0% | ||||
| Joseph Kaplan | 8.0% | ||||
|
Arbutus Biopharma Corp
13D/A
Amendment 3
ABUS · 03879J100
|
8.1% |
4/13/2026
Event 4/10/2026
|
|||
| Whitefort Capital Master Fund, LP | 8.1% | ||||
| Whitefort Capital GP, LLC | 8.1% | ||||
| Whitefort Capital Management, LP | 8.1% | ||||
| Whitefort Capital Management GP, LLC | 8.1% | ||||
| David Salanic | 8.1% | ||||
| Joseph Kaplan | 8.1% | ||||
|
Bally's Corp
13G/A
Amendment 1
BALY · 05875B304
|
4.9% |
3/12/2026
Event 3/12/2026
|
|||
| Whitefort Capital Management, LP | 4.9% | ||||
| David Salanic | 4.9% | ||||
| Joseph Kaplan | 4.9% | ||||
|
Bally's Corp
13G
BALY · 05875B304
|
5.1% |
3/9/2026
Event 3/6/2026
|
|||
| Whitefort Capital Management, LP | 5.1% | ||||
| David Salanic | 5.1% | ||||
| Joseph Kaplan | 5.1% | ||||
|
OmniAb, Inc.
13G/A
Amendment 2
OABI · 68218J103
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
| Whitefort Capital Management, LP | 9.9% | ||||
| David Salanic | 9.9% | ||||
| Joseph Kaplan | 9.9% | ||||
|
INNOVATE Corp.
13G/A
Amendment 1
VATE · 45784J303
|
7.8% |
11/14/2025
Event 9/30/2025
|
|||
| Whitefort Capital Management, LP | 7.8% | ||||
| David Salanic | 7.8% | ||||
| Joseph Kaplan | 7.8% | ||||
|
OmniAb, Inc.
13G/A
Amendment 1
OABI · 68218J103
|
8.4% |
8/14/2025
Event 6/30/2025
|
|||
| Whitefort Capital Management, LP | 8.4% | ||||
| David Salanic | 8.4% | ||||
| Joseph Kaplan | 8.4% | ||||
|
OmniAb, Inc.
13G
OABI · 68218J103
|
6.0% |
6/6/2025
Event 5/30/2025
|
|||
| Whitefort Capital Management, LP | 6.0% | ||||
| David Salanic | 6.0% | ||||
| Joseph Kaplan | 6.0% | ||||
|
Arbutus Biopharma Corp
13D/A
Amendment 2
ABUS · 03879J100
|
7.0% |
2/21/2025
Event 2/20/2025
|
|||
| Whitefort Capital Master Fund, LP | 7.0% | ||||
| Whitefort Capital GP, LLC | 7.0% | ||||
| Whitefort Capital Management, LP | 7.0% | ||||
| Whitefort Capital Management GP, LLC | 7.0% | ||||
| David Salanic | 7.0% | ||||
| Joseph Kaplan | 7.0% | ||||
|
INNOVATE Corp.
13G
VATE · 45784J303
|
7.6% |
1/24/2025
Event 1/21/2025
|
|||
| Whitefort Capital Management, LP | 7.6% | ||||
| David Salanic | 7.6% | ||||
| Joseph Kaplan | 7.6% | ||||